Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/06/2025
Foreign investors' holdings of U.S. government bonds in April were close to a record high level.
Latest
3 m ago
Galaxy Securities China: Optimistic about innovative drugs in the second half of the year, focus on the rebound of equipment and service growth.
3 m ago
Galaxy Securities of China pointed out that they continue to have confidence in the growth of innovative drugs and expect an increase in the speed of growth in equipment and services in the second half of 2025. 1) They continue to be optimistic about medical innovation: in the second half of the year, it is expected that innovative drugs will continue to see valuation improvement due to the expected push from domestic Class B catalog and commercial insurance policies. 2) Medical investment and financing are expected to recover: the prosperity of the secondary market is expected to bring about a rebound in primary market investment and financing, as CXO and upstream sentiment improve. 3) Medical equipment is expected to bottom out and rebound: bidding data has started to improve, and pent-up demand for replacement is gradually being released. 4) The growth rate of medical services is expected to reach a turning point: the nationwide DRG/DIP payment reform has achieved overall coverage in pilot areas, and signs of recovery in the ophthalmology field are emerging. 5) Medical consumption is waiting for recovery: observing the effects of domestic consumption stimulus policies, it is expected that the clearance of channel inventory and the recovery of end demand will be beneficial to the revival of medical consumption. In terms of investment recommendations, the significant valuation repair of the medical innovative drug sector in 2025 is expected to drive the recovery of other sectors in the second half of the year. They are optimistic about the innovative drug industry chain, leading companies in specific industries, and the revival of medical consumption.
4 m ago
Spot gold has just broken through the $3380.00 per ounce mark, currently trading at $3380.15 per ounce, up 0.32% on the day; COMEX gold futures are currently trading at $3397.00 per ounce, down 0.33% on the day.
4 m ago
The South Korean composite index reversed its opening gains and is now down 0.4%, at 2961.40 points.
5 m ago
Institution: American consumers are more pessimistic about the cost of tariffs.
See all latest